학술논문

The utility of pharmacogenetic testing to support the treatment of bipolar disorder.
Document Type
Article
Source
Pharmacogenomics & Personalized Medicine; Mar2018, Vol. 11, p35-42, 8p
Subject
BIPOLAR disorder
THERAPEUTICS
PHARMACOGENOMICS
MEDICAL care costs
ADVERSE health care events
INDIVIDUALIZED medicine
Language
ISSN
11787066
Abstract
Copyright of Pharmacogenomics & Personalized Medicine is the property of Dove Medical Press Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)